JAMES F CASELLA, M.D.
Medical Practice at Wolfe St, Baltimore, MD
License number
Maryland D25599
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(410) 955-6132
Personal information
See more information about JAMES F CASELLA at radaris.comName
Address
Phone
5109 Falls Road Ter, Baltimore, MD 21210
5109 Falls Road Ter, Baltimore, MD 21210
11 Navaho Trl, Elkton, MD 21921
Organization information
See more information about JAMES F CASELLA at bizstanding.comJames F Casella
720 Rutland Ave, Baltimore, MD 21205
Industry:
Medical Doctor's Office
Doing business as:
James F Casella MD
Phone:
(410) 955-6132 (Phone)
Administrative Managers:
James Casella (Owner),Peter Medical Doctor, inactive,Xiaofeng Associate, inactive,...
Categories:
Hematology Physicians & Surgeons, Oncology Physicians & Surgeons, Pediatrics Physicians & Surgeons
James F Casella MD
5109 Fls Rd Ter, Baltimore, MD 21210
Industry:
Medical Doctor's Office
Medical Doctor:
James Casella (Medical Doctor)
Professional information
Dr. James F Casella, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Pediatric Hematology & Oncology
Address:
600 N Wolfe St, Baltimore 21287
Johns Hopkins Univ Pedtrc Hem
200 N Wolfe St SUITE LL, Baltimore 21287
(410) 955-6132 (Phone)
Johns Hopkins Univ Pedtrc Hem
200 N Wolfe St SUITE LL, Baltimore 21287
(410) 955-6132 (Phone)
Certifications:
Pediatric Oncology & Pediatric Hematology, 1982, Pediatrics, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
600 N Wolfe St, Baltimore 21287
Johns Hopkins Univ Pedtrc Hem
200 N Wolfe St SUITE LL, Baltimore 21287
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
Johns Hopkins Univ Pedtrc Hem
200 N Wolfe St SUITE LL, Baltimore 21287
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
Education:
Medical School
SUNY Upstate Med Univ
Graduated: 1976
Johns Hopkins
SUNY Upstate Med Univ
Graduated: 1976
Johns Hopkins
James F Casella, Baltimore MD
Specialties:
Pediatrician
Address:
720 Rutland Ave, Baltimore, MD 21205
600 N Wolfe St, Baltimore, MD 21287
600 N Wolfe, Baltimore, MD 21287
600 N Wolfe St, Baltimore, MD 21287
600 N Wolfe, Baltimore, MD 21287
Education:
State University of New York, Upstate Medical University - Doctor of Medicine
Johns Hopkins Hospital - Fellowship - Hematology and Oncology (Internal Medicine)
Johns Hopkins Hospital - Residency - Pediatrics
Johns Hopkins Hospital - Fellowship - Hematology and Oncology (Internal Medicine)
Johns Hopkins Hospital - Residency - Pediatrics
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)
James Francis Casella, Baltimore MD
Specialties:
Pediatrics, Pediatric Hematology-Oncology, Surgery, Family Medicine, Hematology, Medical Oncology, Hematology
Work:
The Johns Hopkins Hospital
600 N Wolfe St, Baltimore, MD 21287 Johns Hopkins University
720 Rutland Ave, Baltimore, MD 21205
600 N Wolfe St, Baltimore, MD 21287 Johns Hopkins University
720 Rutland Ave, Baltimore, MD 21205
Education:
Upstate Medical University Physical Medicine and Rehabilitation (1976)
Biomarkers Of Brain Injury
US Patent:
2014004, Feb 13, 2014
Filed:
Oct 14, 2011
Appl. No.:
13/879470
Inventors:
Allan Dale Everett - Glenwood MD, US
James Francis Casella - Baltimore MD, US
Jennifer Van Eyk - Baltimore MD, US
James Francis Casella - Baltimore MD, US
Jennifer Van Eyk - Baltimore MD, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
G01N 33/68
US Classification:
506 9, 506 18, 436501, 435 74, 435 794
Abstract:
The present invention relates to the field of biomarkers. More specifically, the present invention relates to biomarkers useful in diagnosing brain injuries. Brain injury can include overt or traumatic brain injury, as well as subclinical brain injury (SCI). In one embodiment, a method for diagnosing SCI in a patient comprises (a) collecting a sample from the patient; (b) measuring the levels of a panel of biomarkers in the sample collected from the patient, wherein the panel of biomarkers comprises ASTN1, BAI3, CNDP1, ERMIN, GFAP, GRM3, KLH32, MAGE2, NRG3, NRGN, OMG, SLC39A12, RTN1, and MT3; and (c) comparing the levels of the panel of biomarkers with predefined levels of the same panel of biomarkers that correlate to a patient having SCI and predefined levels of the same panel of biomarkers that correlate to a patient not having SCI, wherein a correlation to one of the predefined levels provides the diagnosis.